JNJ vs LXFR · P/E 17, rev $49.37B vs P/E 16, rev $181.4M
Johnson & Johnson (JNJ) versus Luxfer Holdings PLC (LXFR) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Luxfer Holdings PLC (LXFR) is a specialty industrial machinery company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported LXFR revenue for 2026-06-28 was $181.4M. Net income was $8.4M. LXFR currently screens at market cap $345.4M and trailing P/E 16.3.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. LXFR currently screens at market cap $345.4M and trailing P/E 16.3.
Not investment advice. Open the JNJ and LXFR stock pages for the full models.
Not investment advice.